Ismael, Musa M.

HRN: 24-46-58  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/26/2024
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
01/26/2024
02/02/2024
IVTT
1.5 Gram
Q6H
Cellulitis
Waiting Final Action 
01/26/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
01/26/2024
02/02/2024
IVTT
600mg
Q8H
Cellulitis
Waiting Final Action 
02/03/2024
CLINDAMYCIN 300MG (CAP)
02/03/2024
02/10/2024
PO
300mg
TID
Cellulitis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: